Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling

Molecular and Cellular Biology

Volumn 31, Issue 23, 2011, Pages 4775-4788

  Kim, Nam Shik ^a,b   Kim, Hyoung Tai ^a   Kwon, Min Chul ^a   Choi, Suk Won ^a   Kim, Yoon Young ^b   Yoon, Ki Jun ^a   Koo, Bon Kyoung ^a   Kong, Myung Phil ^b   Shin, Juhee ^b   Cho, Yunje ^b   Kong, Young Yun ^a  

^a Seoul National University   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 2; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; EPITHELIUM CELL; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE KNOCKOUT TECHNIQUES; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; LACTATION; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MILK PROTEINS; PHOSPHORYLATION; PREGNANCY; PROTEIN TRANSPORT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 83255186733     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05646-11     Document Type: Article

References (43)

1. Anderson, D. M., et al. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179.
2. Asselin-Labat, M. L., et al. 2010. Control of mammary stem cell function by steroid hormone signalling. Nature 465:798-802.
3. Beleut, M., et al. 2010. Two distinct mechanisms underlie progesteroneinduced proliferation in the mammary gland. Proc. Natl. Acad. Sci. U. S. A. 107:2989-2994.
4. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
5. Brisken, C. 2002. Hormonal control of alveolar development and its implications for breast carcinogenesis. J. Mammary Gland Biol. Neoplasia 7:39-48.
6. Brisken, C., et al. 2002. IGF-2 is a mediator of prolactin-induced morphogenesis in the breast. Dev. Cell 3:877-887.
7. Cao, Y., et al. 2001. IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107:763-775.
8. Cartwright, P., and K. Helin. 2000. Nucleocytoplasmic shuttling of transcription factors. Cell. Mol. Life Sci. 57:1193-1206.
9. Fabbro, M., and B. R. Henderson. 2003. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282:59-69.
10. Fata, J. E., et al. 2000. The osteoclast differentiation factor osteoprotegerinligand is essential for mammary gland development. Cell 103:41-50.
11. Gonzalez-Suarez, E., et al. 2010. RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 468:103-107.
12. Hara, E., M. Hall, and G. Peters. 1997. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. EMBO J. 16:332-342.
13. Hennighausen, L., and G. W. Robinson. 2001. Signaling pathways in mammary gland development. Dev. Cell 1:467-475.
14. Hennighausen, L., and G. W. Robinson. 1998. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12:449-455.
15. Indra, A. K., et al. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 27:4324-4327.
16. Jones, D. H., et al. 2006. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692-696.
17. Joshi, P. A., et al. 2010. Progesterone induces adult mammary stem cell expansion. Nature 465:803-807.
18. Kim, H. J., M. J. Yoon, J. Lee, J. M. Penninger, and Y. Y. Kong. 2002. Osteoprotegerin ligand induces beta-casein gene expression through the transcription factor CCAAT/enhancer-binding protein beta. J. Biol. Chem. 277:5339-5344.
19. Kim, N. S., et al. 2006. Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2. Mol. Cell. Biol. 26:1002-1013.
20. Kong, Y. Y., et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
21. Kurooka, H., and Y. Yokota. 2005. Nucleo-cytoplasmic shuttling of Id2, a negative regulator of basic helix-loop-helix transcription factors. J. Biol. Chem. 280:4313-4320.
22. Lacey, D. L., et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
23. Lasorella, A., and A. Iavarone. 2006. The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system. Proc. Natl. Acad. Sci. U. S. A. 103:4976-4981.
24. Lasorella, A., et al. 2006. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature 442:471-474.
25. Li, X., et al. 2005. Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat. Cell Biol. 7:1202-1212.
26. Lombardi, M., et al. 2008. Hormone-dependent nuclear export of estradiol receptor and DNA synthesis in breast cancer cells. J. Cell Biol. 182:327-340.
27. Matsumura, M. E., D. R. Lobe, and C. A. McNamara. 2002. Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation. J. Biol. Chem. 277:7293-7297.
28. Miyoshi, K., et al. 2002. Mammary epithelial cells are not able to undergo pregnancy-dependent differentiation in the absence of the helix-loop-helix inhibitor Id2. Mol. Endocrinol. 16:2892-2901.
29. Miyoshi, K., et al. 2001. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J. Cell Biol. 155:531-542.
30. Mori, S., S. I. Nishikawa, and Y. Yokota. 2000. Lactation defect in mice lacking the helix-loop-helix inhibitor Id2. EMBO J. 19:5772-5781.
31. Mulac-Jericevic, B., J. P. Lydon, F. J. DeMayo, and O. M. Conneely. 2003. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U. S. A. 100:9744-9749.
32. Norton, J. D., R. W. Deed, G. Craggs, and F. Sablitzky. 1998. Id helix-loophelix proteins in cell growth and differentiation. Trends Cell Biol. 8:58-65.
33. Rane, M. J., et al. 2001. p38 kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem. 276:3517-3523.
34. Romieu-Mourez, R., et al. 2003. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors. Mol. Cell. Biol. 23:5738-5754.
35. Samanta, J., and J. A. Kessler. 2004. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131:4131-4142.
36. Schramek, D., et al. 2010. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 468:98-102.
37. Shillingford, J. M., K. Miyoshi, M. Flagella, G. E. Shull, and L. Hennighausen. 2002. Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: characterization, localization, and involvement in ductal development and morphogenesis. Mol. Endocrinol. 16:1309-1321.
38. Sinn, E., et al. 1987. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465-475.
39. Smith, J. M., and P. A. Koopman. 2004. The ins and outs of transcriptional control: nucleocytoplasmic shuttling in development and disease. Trends Genet. 20:4-8.
40. Srivastava, S., et al. 2003. Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. J. Biol. Chem. 278:46171-46178.
41. Tu, X., R. Baffa, S. Luke, M. Prisco, and R. Baserga. 2003. Intracellular redistribution of nuclear and nucleolar proteins during differentiation of 32D murine hemopoietic cells. Exp. Cell Res. 288:119-130.
42. Wang, S., A. Sdrulla, J. E. Johnson, Y. Yokota, and B. A. Barres. 2001. A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron 29:603-614.
43. Yokota, Y., et al. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397:702-706.